T-Cell Engager for Autoimmune Disease Summit
October 14-16, 2025 | Boston, MA
Accelerate the Development of T-Cell Engagers in Autoimmune Indications Through Reducing CRS Toxicities, Improve Tissue Targeted Depletion & Expand Targets Beyond B-Cells.
The T-Cell Engager for Autoimmune Disease Summit is the first event dedicated entirely to advancing TCE therapies for autoimmune and inflammatory conditions. Over three days, this focused meeting brings together top immunology experts, pioneering biotech leaders, and pharmaceutical innovators to address critical challenges in design, safety, and clinical application.
8th TPD & Induced Proximity Summit
October 27-30, 2025 | Boston, MA
Accelerating the Discovery, Development & Regulatory Advancement of First-in-Class, Selective, Safe & Effective Degraders & Proximity-Based Therapeutics to Unlock the Undruggable
Now in its 8th year, the TPD & Induced Proximity Summit returns as the industry’s leading meeting uniting discovery through clinical development for proximity-based modalities. Bringing together pioneers such as Arvinas, Nurix, C4 Therapeutics, emerging players like Larkspur Bio, Magnet Biomedicine, and TrimTech, plus TPD co-founders Craig Crews and Ray Deshaies, this is the premier forum to access the latest clinical insights, build strategic partnerships, and harness the vast potential of these therapies to address high unmet patient needs.
16th World ADC San Diego Summit
November 3-6, 2025 | San Diego, CA.
Driving Progress with Innovation in ADC Chemistry, Enhancing Patient Stratification in Clinical Trials, and Maximizing Manufacturing Efficiency to Advance ADCs Toward Standard-of-Care Oncology Therapies
Featuring 7 comprehensive streams covering discovery chemistry, discovery biology, preclinical research, translational medicine, clinical insights, process and analytical development, plus manufacturing and supply chain, this is your all-in-one bioconjugate meeting. Equip your team with ADC fundamentals, overcome key challenges slowing R&D, and spot emerging trends to stay at the forefront of the field.
7th Targeted Radiopharmaceuticals Summit
November 10-12, 2025 | Amsterdam, NE
Position Targeted Radiopharmaceuticals as the Next Major Class of Oncology Therapeutics by Advancing Novel Design Strategies, Highlighting Breakthrough Clinical Data, and Enhancing Isotope Supply and Distribution Efficiency
The 7th Targeted Radiopharmaceuticals Summit Europe is where the global TRP community comes together to drive the field forward. From discovery and clinical development to manufacturing and regulation, gain actionable insights, engage in candid discussions, and uncover practical solutions. Together, we’ll shape the roadmap that turns RLTs from potential into practice.
3rd Cell Therapy for Autoimmune Disease Summit
December 2-4, 2025 | Philadelphia, PA
Drive Transformative Therapeutic & Clinical Advances in Diverse Autoimmune Cell Therapies with Demonstrated Safety, Durable Efficacy & Improved Patient Accessibility to Redefine the Long-Term Management of Autoimmune Diseases
The 3rd Cell Therapy for Autoimmune Disease Summit arrives at a pivotal time, with autoimmune therapies set to shape the next wave of cell therapy innovation. As the sole meeting dedicated to advances in CAR-T, Treg, NK, and in vivo approaches, it offers a unique chance to gain comprehensive insights and successfully navigate the fast-evolving path to market.
Search